CellaVision Valuation
| CEVI Stock | SEK 214.50 3.00 1.42% |
At this time, the firm appears to be overvalued. CellaVision AB shows a prevailing Real Value of kr160.88 per share. The current price of the firm is kr214.5. Our model approximates the value of CellaVision AB from analyzing the firm fundamentals such as Return On Equity of 0.2, current valuation of 6.21 B, and Profit Margin of 0.19 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that CellaVision's price fluctuation is very steady at this time. Calculation of the real value of CellaVision AB is based on 3 months time horizon. Increasing CellaVision's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
CellaVision's intrinsic value may or may not be the same as its current market price of 214.50, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 214.5 | Real 160.88 | Hype 214.5 | Naive 215.59 |
The intrinsic value of CellaVision's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence CellaVision's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of CellaVision AB helps investors to forecast how CellaVision stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CellaVision more accurately as focusing exclusively on CellaVision's fundamentals will not take into account other important factors: CellaVision Total Value Analysis
CellaVision AB is currently anticipated to have takeover price of 6.21 B with market capitalization of 5.21 B, debt of 95.84 M, and cash on hands of 190.2 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the CellaVision fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
6.21 B | 5.21 B | 95.84 M | 190.2 M |
CellaVision Investor Information
About 38.0% of the company shares are held by company insiders. The company recorded earning per share (EPS) of 5.27. CellaVision AB last dividend was issued on the 12th of May 2022. Based on the analysis of CellaVision's profitability, liquidity, and operating efficiency, CellaVision AB is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.CellaVision Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. CellaVision has an asset utilization ratio of 68.53 percent. This implies that the Company is making kr0.69 for each dollar of assets. An increasing asset utilization means that CellaVision AB is more efficient with each dollar of assets it utilizes for everyday operations.CellaVision Ownership Allocation
CellaVision holds a total of 23.85 Million outstanding shares. CellaVision AB retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.CellaVision Profitability Analysis
The company reported the revenue of 565.55 M. Net Income was 158.3 M with profit before overhead, payroll, taxes, and interest of 438.32 M.About CellaVision Valuation
The stock valuation mechanism determines CellaVision's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of CellaVision AB based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of CellaVision. We calculate exposure to CellaVision's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of CellaVision's related companies.CellaVision AB develops and sells digital solutions for blood and body fluids analysis in health care services sector in Sweden and internationally. CellaVision AB was founded in 1994 and is headquartered in Lund, Sweden. CellaVision operates under High Precision And Instrumentation Products classification in Sweden and is traded on Stockholm Stock Exchange. It employs 129 people.
8 Steps to conduct CellaVision's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates CellaVision's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct CellaVision's valuation analysis, follow these 8 steps:- Gather financial information: Obtain CellaVision's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine CellaVision's revenue streams: Identify CellaVision's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research CellaVision's industry and market trends, including the size of the market, growth rate, and competition.
- Establish CellaVision's growth potential: Evaluate CellaVision's management, business model, and growth potential.
- Determine CellaVision's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate CellaVision's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for CellaVision Stock Analysis
When running CellaVision's price analysis, check to measure CellaVision's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CellaVision is operating at the current time. Most of CellaVision's value examination focuses on studying past and present price action to predict the probability of CellaVision's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CellaVision's price. Additionally, you may evaluate how the addition of CellaVision to your portfolios can decrease your overall portfolio volatility.